Low-grade inflammation differentiates between symptoms of apathy and depression in community-dwelling older individuals

International Psychogeriatrics

Volumn 27, Issue 4, 2015, Pages 639-647

  Eurelings, Lisa S M ^a   Richard, Edo ^b   Eikelenboom, Piet ^a,c,d   Van Gool, Willem A ^a   Moll Van Charante, Eric P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GGZ InGeest   (Netherlands)

Author keywords

apathy; C reactive protein; cardiovascular disease; depression; inflammation

Indexed keywords

C REACTIVE PROTEIN;

AGED; APATHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DEPRESSION; ELDERLY CARE; FEMALE; FOLLOW UP; GERIATRIC DEPRESSION SCALE; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; INDEPENDENT LIVING; LONGITUDINAL STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; APATHY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INDEPENDENT LIVING; INFLAMMATION; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84924271594     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610214002683     Document Type: Article

References (29)

1. Allin, K. H. and Nordestgaard, B. G. (2011). Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Critical Reviews in Clinical Laboratory Sciences, 48, 155-170. doi: 10.3109/10408363.2011.599831.
2. Bisoendial, R. J., Boekholdt, S. M., Vergeer, M., Stroes, E. S. G. and Kastelein, J. J. P. (2010). C-reactive protein is a mediator of cardiovascular disease. European Heart Journal, 31, 2087-2091. doi:10.1093/eurheartj/ehq238.
3. Brodaty, H., Sachdev, P. S., Withall, A., Altendorf, A., Valenzuela, M. J. and Lorentz, L. (2005). Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke - the Sydney Stroke Study. Psychological Medicine, 35, 1707-1716. doi:10.1017/S0033291705006173.
4. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W. and Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience, 9, 46-56. doi:10.1038/nrn2297.
5. Duivis, H. E., Vogelzangs, N., Kupper, N., de Jonge, P. and Penninx, B. W. J. H. (2013). Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands study of depression and anxiety (NESDA). Psychoneuroendocrinology, 38, 1573-1585. doi: 10.1016/j.psyneuen.2013.01.002.
6. Eurelings, L. S. M., Jaccard, J., Moll van Charante, E. P., Ligthart, S. A., Van Gool, W. A. and Richard, E. (2014b).The mediating role of cardiovascular risk factors in the relationship between symptoms of apathy, depression, and incident cardiovascular disease in older individuals. Submitted.
7. Eurelings, L. S. M., Ligthart, S. A., Van Dalen, J. W., Moll Van Charante, E. P., Van Gool, W.A. and Richard, E. (2014a). Apathy is an independent risk factor for incident cardiovascular disease in the older individual: a population-based cohort study. International Journal of Geriatric Psychiatry, 29, 454-463. doi:10.1002/gps.4026.
8. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198. doi:10.1016/0022-3956(75)90026-6.
9. Fones, C. S. (1998). Distinguishing apathy syndromes from vascular depression. Archives of General Psychiatry, 55, 844-845. doi:10.1001/archpsyc.55.9.844.
10. Guimarães, H. C., Caramelli, P., de Paula Franc¸a, E., Afonso, M. P. D., Fialho, P. P. A. and Teixeira, A. L. (2013). Serum levels of soluble TNF-α receptors but not BDNF are associated with apathy symptoms in mild Alzheimer's disease and amnestic mild cognitive impairment. Dementia e Neuropsychologia, 7, 298-303.
11. Hall, J. R., Johnson, L. A., Vo, H. T., Barber, R. C., Winter, S. and O'Bryant, S. E. (2012). Biomarkers and depressive symptoms in older women with and without cognitive impairment. Journal of Behavioral and Brain Science, 2, 276-281. doi: 10.4236/jbbs.2012.22031.
12. Hall, J. R., Vo, H. T., Johnson, L. A., Winter, S., Barber, R. C. and O'Bryant, S. E. (2011). Biomarkers and depressive symptoms in a sample of cognitively intact and Alzheimer's Disease elderly males. Neuroscience & Medicine, 2, 306-312. doi: 10.4236/nm.2011.24040.
13. Heringa, S. M. et al. (2014). Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population - the Hoorn Study. Psychoneuroendocrinology, 40, 108-118. doi: 10.1016/j.psyneuen.2013.11.011.
14. Hoth, K. F. et al. (2008). Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. Journal of the American Geriatrics Society, 56, 1898-1903. doi: 10.1111/j.1532-5415.2008.01930.x.
15. Howren, M. B., Lamkin, D. M. and Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine, 71, 171-186. doi: 10.1097/PSY.0b013e3181907c1b
16. Inagaki, M. et al. (2013). Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients. Supportive Care in Cancer, 21, 2097-2106. doi: 10.1007/s00520-013-1767-x.
17. Lesher, E. L. and Berryhill, J. S. (1994). Validation of the geriatric depression scale-short Form among inpatients. Journal of Clinical Psychology, 50, 256-260. doi: 10.1002/1097-4679(199403)50:2〈256::AIDJCLP2270500218〉3.0.CO;2-E.
18. Ligthart, S. A. et al. (2012). Association of vascular factors with apathy in community-dwelling elderly individuals. Archives of General Psychiatry, 69, 636-642. doi:10.1001/archgenpsychiatry.2011.1858.
19. Lima, T. A. S. et al. (2014). C-reactive protein, APOE genotype and longitudinal cognitive change in an older population. Age and Ageing, 43, 289-292. doi: 10.1093/ageing/aft193.
20. Luppa, M. et al. (2012). Age- and gender-specific prevalence of depression in latest-life-systematic review and meta-analysis. Journal of Affective Disorders, 136, 212-221. doi:10.1016/j.jad.2010.11.033.
21. Maas, D. W., Van der Mast, R. C. and de Craen, A. J. M. (2009). Increased C-reactive protein is not associated with apathy: the Leiden 85-Plus Study. International Journal of Geriatric Psychiatry, 24, 1177-1184. doi: 10.1002/gps.2242.
22. Marin, R. S., Firinciogullari, S. and Biedrzycki, R. C. (1993). The sources of convergence between measures of apathy and depression. Journal of Affective Disorders, 28, 7-14. doi: 10.1016/0165-0327(93)90072-R.
23. Richard, E. et al. (2009). Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Disease and Associated Disorders, 23, 198-204. doi:10.1097/WAD.0b013e31819783a4.
24. Ridker, P. M. (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107, 363-369. doi: 10.1161/01.CIR.0000053730.47739.3C.
25. Robert, P. et al. (2009). Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. European Psychiatry, 24, 98-104. doi:10.1016/j.eurpsy.2008.09.001
26. Valkanova, V., Ebmeier, K. P. and Allan, C. L. (2013). CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. Journal of Affective Disorders, 150, 736-744. doi: 10.1016/j.jad.2013.06.004.
27. Van der Mast, R. C. et al. (2008). Vascular disease and apathy in old age. The Leiden 85-Plus Study. International Journal of Geriatric Psychiatry, 23, 266-271. doi: 10.1002/gps.1872.
28. Van Reekum, R., Stuss, D. T. and Ostrander, L. (2005). Apathy: why care? The Journal of Neuropsychiatry and Clinical Neurosciences, 17, 7-19. doi:10.1176/appi.neuropsych.17.1.7.
29. Wilkins, V. M., Kiosses, D. and Ravdin, L. D. (2010). Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions. Clinical Interventions in Aging, 5, 323-331. doi: 10.2147/CIA.S9088.